Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 2006

View Archived Issues

LBH-589: new candidate for multiple myeloma

Bioheart to receive grant to develop adult stem cell therapies

Pivotal trial for Auxilium's testosterone transmucosal film in hypogonadism

Invitrogen licenses Geron's hESC related intellectual property

MedImmune steps up efforts to develop vaccines for pediatric respiratory diseases

Treatment completed in phase I/II study of Aastrom's Tissue Repair Cells

Series A financing supports Innovive pipeline development

Medivir licenses antiviral projects to Tibotec, extends HCV research collaboration

KineMed to seek new applications for discontinued Organon compound

Avanir awarded NIAID grant for human antibody to anthrax toxin

Neupro filed in Europe for advanced Parkinson's disease

SkyePharma withdraws European filing for DepoCyte

Ethics approval for phase I study of Phosphagenics' transdermal insulin product

Micardis filed in Japan for type 2 diabetic nephropathy

Review of intracranial hemorrhage reports in Aptivus clinical trials

E-6801: a new 5-HT6 agonist with procognitive properties

Ezetimibe adds to rosuvastatin efficacy in hypercholesterolemic patients

Phase II studies show antitumor activity of panitumumab in metastatic colorectal cancer

Snapshots of new results with sunitinib in gastrointestinal stromal tumors

Study finds no resistance mutations with bevirimat in HIV patients

MD-0727 safe in healthy volunteers

CoFactor activity in colorectal cancer and infusion pharmacokinetics reported

THR-0921 active in arthritis model

Cardioprotective effects of a novel NHE-1 inhibitor

European CHMP hands down positive opinion for Exjade

New DatSCAN indication recommended for approval in Europe

Preclinical pharmacology and cardiovascular safety of COX-2 inhibitor CS-706 reported

Downregulation of Rho-GTPase activity may explain KJ-0530's neuroprotective effects

Recent patents cover therapeutics for Alzheimer's disease

Recent Roche and Lilly patents impart new agents for obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....